Craig A. Cooney

Craig A. Cooney

Auto-generated profile, based on publicly available information

Craig A. Cooney

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 1998 in The FASEB Journal
Verified
Journal Article
Closed access
GWGeorge L. Wolff
George L. Wolff
RKRalph L. Kodell
Ralph L. Kodell
SMStephen R. Moore
Stephen R. Moore
CCCraig A. Cooney
Craig A. Cooney

1 August 2002 in The Journal of Nutrition
Verified
Journal Article
Closed access
CCCraig A. Cooney
Craig A. Cooney
ADApurva A. Dave
Apurva A. Dave
GWGeorge L. Wolff
George L. Wolff
This study was designed to determine if maternal dietary methyl supplements increase DNA methylation and methylation-dependent epigenetic phenotypes in mammalian offspring. Female mice of two strains were fed two levels of dietary methyl supplement or control diet prior to and during pregnancy. Offspring of these mice vary in phenotype, which is epigenetically determined and affects health and 2-y survival. Phenotype and DNA methylation of a long terminal repeat (LTR) controlling expression of the agouti gene were assayed in the resulting offspring. Methyl supplements increase the level of DNA methylation in the agouti LTR and change the phenotype of offspring in the healthy, longer-lived direction. This shows that methyl supplements have strong effects on DNA methylation and phenotype and are likely to affect long-term health. Optimum dietary supplements for the health and longevity of offspring should be intensively investigated. This should lead to public policy guidance that teaches optimal, rather than minimal, dose levels of maternal supplements.

9 June 2011 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
CCCraig A Cooney
Craig A Cooney
FJFariba Jousheghany
Fariba Jousheghany
AYAiwei Yao-Borengasser
Aiwei Yao-Borengasser
BPBounleut Phanavanh
Bounleut Phanavanh
TGTina Gomes
Tina Gomes
BMBehjatolah Monzavi-Karbassi
Behjatolah Monzavi-Karbassi
We have previously demonstrated that chondroitin sulfate glycosaminoglycans (CS-GAGs) on breast cancer cells function as P-selectin ligands. This study was performed to identify the carrier proteoglycan (PG) and the sulfotransferase gene involved in synthesis of the surface P-selectin-reactive CS-GAGs in human breast cancer cells with high metastatic capacity, as well as to determine a direct role for CS-GAGs in metastatic spread. Quantitative real-time PCR (qRT-PCR) and flow cytometry assays were used to detect the expression of genes involved in the sulfation and presentation of chondroitin in several human breast cancer cell lines. Transient transfection of the human breast cancer cell line MDA-MB-231 with the siRNAs for carbohydrate (chondroitin 4) sulfotransferase-11 (CHST11) and chondroitin sulfate proteoglycan 4 (CSPG4 ) was used to investigate the involvement of these genes in expression of surface P-selectin ligands. The expression of CSPG4 and CHST11 in 15 primary invasive breast cancer clinical specimens was assessed by qRT-PCR. The role of CS-GAGs in metastasis was tested using the 4T1 murine mammary cell line (10 mice per group). The CHST11 gene was highly expressed in aggressive breast cancer cells but significantly less so in less aggressive breast cancer cell lines. A positive correlation was observed between the expression levels of CHST11 and P-selectin binding to cells (P < 0.0001). Blocking the expression of CHST11 with siRNA inhibited CS-A expression and P-selectin binding to MDA-MB-231 cells. The carrier proteoglycan CSPG4 was highly expressed on the aggressive breast cancer cell lines and contributed to the P-selectin binding and CS-A expression. In addition, CSPG4 and CHST11 were over-expressed in tumor-containing clinical tissue specimens compared with normal tissues. Enzymatic removal of tumor-cell surface CS-GAGs significantly inhibited lung colonization of the 4T1 murine mammary cell line (P = 0.0002). Cell surface P-selectin binding depends on CHST11 gene expression. CSPG4 serves as a P-selectin ligand through its CS chain and participates in P-selectin binding to the highly metastatic breast cancer cells. Removal of CS-GAGs greatly reduces metastatic lung colonization by 4T1 cells. The data strongly indicate that CS-GAGs and their biosynthetic pathways are promising targets for the development of anti-metastatic therapies.

1 November 2005 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
JKJim Kaput
Jim Kaput
JOJosé M Ordovás
José M Ordovás
LFLynnette Ferguson
Lynnette Ferguson
BOBen van Ommen
Ben van Ommen
RRRaymond L. Rodriguez
Raymond L. Rodriguez
JZJean-Daniel ZUCKER
Jean-Daniel ZUCKER
Nutrigenomics is the study of how constituents of the diet interact with genes, and their products, to alter phenotype and, conversely, how genes and their products metabolise these constituents into nutrients, antinutrients, and bioactive compounds. Results from molecular and genetic epidemiological studies indicate that dietary unbalance can alter gene–nutrient interactions in ways that increase the risk of developing chronic disease. The interplay of human genetic variation and environmental factors will make identifying causative genes and nutrients a formidable, but not intractable, challenge. We provide specific recommendations for how to best meet this challenge and discuss the need for new methodologies and the use of comprehensive analyses of nutrient–genotype interactions involving large and diverse populations. The objective of the present paper is to stimulate discourse and collaboration among nutrigenomic researchers and stakeholders, a process that will lead to an increase in global health and wellness by reducing health disparities in developed and developing countries.

15 June 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
ASAhmed Mazen Safar
Ahmed Mazen Safar
HSHorace Spencer
Horace Spencer
XSXiaobo Su
Xiaobo Su
MCMaureen Coffey
Maureen Coffey
CCCraig A. Cooney
Craig A. Cooney
CFChun-Yang Fan
Chun-Yang Fan
Purpose: Enhanced prognostication power is becoming more desirable in clinical oncology. In this study, we explored the prognostic potential of multigene hypermethylation profiling in non–small-cell lung cancer.

1 February 2011 in Alcohol
Verified
Journal Article
Closed access
CDChris Downing
Chris Downing
TJThomas E. Johnson
Thomas E. Johnson
CLColin Larson
Colin Larson
TLTatiana I. Leakey
Tatiana I. Leakey
RSRachel N. Siegfried
Rachel N. Siegfried
CCCraig A. Cooney
Craig A. Cooney